Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou do not need to run marathons or join a gym for Mounjaro to work. Tirzepatide is licensed for weight management alongside a reduced-calorie diet and increased physical activity, but the evidence shows the medicine does the heavy lifting on appetite regulation — exercise shapes what you keep after the weight is gone. These are prescription-only medicines, and a prescriber decides whether they are right for you. Here is what the clinical picture actually looks like.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks goes roughly like this: "I'm not exercising much, will it still work?" The short answer is yes, because tirzepatide acts on two gut-hormone receptors (GIP and GLP-1) to reduce appetite and slow gastric emptying, independently of how much you move. The clinical evidence for tirzepatide shows average weight reductions of around 20% at the highest doses in the SURMOUNT-1 trial, and participants in that programme were not required to follow a demanding exercise regimen.
That does not make activity optional in a meaningful sense. What exercise does is protect what you are losing. When the body sheds weight quickly, it loses both fat and lean muscle. Resistance training (bodyweight work, weights, resistance bands) signals to the body to hold onto that muscle. That matters for your metabolism, your long-term weight maintenance, and how you feel day to day. The NHS's guidance on weight management medicines reinforces that physical activity is part of the treatment framework precisely for this reason.
So the reframe is this: exercise is not the engine of weight loss on Mounjaro; it is the quality-control layer. If you are weighing up whether you should exercise on Mounjaro, the honest answer is that it is about protecting your results rather than unlocking them. Drop the expectation that you need to earn the medicine through sweat, and focus instead on moving in ways that build or preserve muscle.
The first few weeks on tirzepatide are an adjustment period. Nausea, fatigue and reduced appetite are common as your body acclimates, and these can affect how much energy you have for exercise. Pushing through a demanding session when you feel nauseous is not a good idea and is not what the medicine asks of you.
Eating less also means taking in fewer calories, and if protein intake drops significantly, you will have less fuel for recovery. This is one reason prescribers and dietitians often emphasise protein adequacy during treatment: aim to keep protein as a priority within whatever you are eating, even when appetite is suppressed. Hydration matters too, GI side effects can quietly tip you towards mild dehydration, which makes exercise feel harder than it should.
Most people find this settles within days to two weeks of a new dose. It is worth noting that starting very gently (a 20-minute walk counts) and building from there is both safe and sensible. The effect of Mounjaro on running is a specific question some people have, particularly if they are already runners, and the answer there involves pacing expectations through dose-increase periods.
If you are experiencing side effects that are making any physical activity difficult, that is worth raising with your prescriber rather than pushing through silently.
There is no single prescribed approach. The broad evidence base for weight-management medicine supports combining resistance or strength work with moderate aerobic activity. Resistance exercise two to three times a week is a reasonable starting structure for most people, this does not require a gym. Bodyweight exercises at home, swimming, cycling, yoga with resistance elements, or working with a physiotherapist if mobility is limited all count.
Walking is consistently underestimated. A 30-minute daily walk at a brisk pace contributes meaningfully to cardiovascular health and supports mental wellbeing during a period when appetite and eating patterns are changing, sometimes disorienting. The NHS's healthy weight guidance points to activity being cumulative, it does not all have to happen in one block.
If you want more structure, a dedicated exercise plan on Mounjaro is worth reading through before you start. The key principles there apply regardless of your starting fitness level. And if you are unsure whether exercise is compulsory for treatment at all, the question of whether exercise is required on Mounjaro is answered directly in another part of our resource section.
For anyone considering tirzepatide, understanding the full Mounjaro treatment overview gives useful context before a consultation. The cost dimension is worth considering too, our treatment page sets out what is included in the price, without hidden extras.
As a prescription medicine, tirzepatide requires clinical assessment. The MHRA's published guidance on GLP-1 medicines for weight loss is clear that these medicines are not assessed for cosmetic weight loss, and suitability is determined by a clinician. At nume (at our GPhC-registered pharmacy) that assessment is carried out personally by a GPhC-registered Independent Prescriber, not automated. You can read the NHS's patient-level guidance on tirzepatide for a thorough overview of the medicine, including side effects, before deciding whether to go ahead.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.